North America Digital Pathology Market Size, Share & Trends Analysis Report By Product (Software, Device), By Application, By End Use (Cancer Hospitals, Diagnostic Labs), By Region, And Segment Forecasts, 2021 - 2028

Table of Contents

Chapter 1 Research Methodology & Scope
1.1 Market Segmentation & Scope
1.1.1 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database:
1.3.2 GVR’s Internal Database
1.3.3 Secondary sources
1.3.4 Primary Research:
1.3.5 Details of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Workflow Analysis (Model 1)
1.7 List of Primary Sources
1.8 List of Secondary Sources
1.9 List of Abbreviations
1.10 Market Definitions
1.11 Report Objectives
Chapter 2 Executive Summary
2.1 Market Outlook
2.1.1 North America North America Digital Pathology Market Outlook, 2016-2027 (USD Million)
2.2 North America North America Digital Pathology Market Summary, 2020
2.3 Segment Outlook
2.4 Regional Insights
2.4.1 U.S.
2.4.1.1 U.S. Digital Pathology market estimates and forecasts, 2016 - 2028 (USD Million)
2.4.2 Canada
2.4.2.1 Canada Digital Pathology market estimates and forecasts, 2016 - 2028 (USD Million)
2.5 Competitive Insights
Chapter 3 North America Digital Pathology Market: Product Estimates & Trend Analysis
3.1 North America Digital Pathology Market: Product Movement Analysis
3.2 Software
3.2.1 Software market estimates and forecasts, 2016 - 2028 (USD Million)
3.3 Devices
3.3.1 Device market estimates and forecasts, 2016 - 2028 (USD Million)
Chapter 4 North America Digital Pathology Market: Application Estimates & Trend Analysis
4.1 North America Digital Pathology Market: Application Movement Analysis
4.2 Drug Discovery & Development
4.2.1 Drug Discovery & Development market estimates and forecasts, 2016 - 2028 (USD Million)
4.3 Academic Research
4.3.1学术研究市场估计和forecasts, 2016 - 2028 (USD Million)
4.4 Disease Diagnosis
4.4.1 Disease Diagnosis market estimates and forecasts, 2016 - 2028 (USD Million)
4.4.2 Cancer cell Detection
4.4.2.1 Cancer cell detection market estimates and forecasts, 2016 - 2028 (USD Million)
4.4.3 Other applications
4.4.3.1 Other applications market estimates and forecasts, 2016 - 2028 (USD Million)
Chapter 5 North America Digital Pathology Market: End-use Estimates & Trend Analysis
5.1 North America Digital Pathology Market: End-use Movement Analysis
5.2 Cancer Hospitals
5.2.1 Hospitals market estimates and forecasts, 2016 - 2028 (USD Million)
5.3 Diagnostic Laboratories
5.3.1 Diagnostic Laboratories MARKET estimates and forecasts, 2016 - 2028 (USD Million)
5.3.2 Independent Pathology Labs
5.3.2.1 Independent Pathology labs market estimates and forecats, 2016 - 2028 (USD Million)
5.3.3 Large Pathology Labs
5.3.3.1 Large Pathology labs market estimates and forecats, 2016 - 2028 (USD Million)
5.4 Academic and Research Institutes
5.4.1 Academic and Research Institutes market estimates and forecasts, 2016 - 2028 (USD Million)
Chapter 6 North America Digital Pathology Market Variables, Trends & Scope
6.1 Market Lineage Outlook
6.1.1 Parent market outlook
6.1.2 Ancillary market outlook
6.2 Penetration & Growth Prospect Mapping
6.3 North America Digital Pathology Market Dynamics
6.3.1 Market Driver Analysis
6.3.1.1 Increasing prevalence of chronic diseases
6.3.1.2 Higher Cost-Efficiency
6.3.1.3 Rapid technological advancement
6.3.2 Market restraint analysis
6.3.2.1 Lack of reimbursement for digital pathology-enabled services
6.3.3 Industry Challenges
6.4 North America Digital Pathology Market Analysis Tools: Porters
6.5 SWOT Analysis By Factors (Political & Legal, Economic, Social and Technology)
6.6 Regulatory Framework
6.6.1 List of regulations
6.7 Political Landscape, Current & Future Scenario
6.7.1 List of regulations
6.8 Cost Structure Analysis
6.8.1 Price Erosion Analysis
Chapter 7 Potential Buyer Analysis
7.1 U.S. Demographic Information and Consumer Market Size
7.1.1 Pathology Laboratories
7.1.2 Hospitals
7.1.3 Academic & Research Institutes
7.2 List of Potential Customers
7.2.1 List of hospitals in the U.S
7.2.2 List of Pathology Laboratoreis in the U.S
7.2.3 Penetration of Digital Pathology
7.2.4 Estimated Penetration of Digital Pathology In Primary Read Vs Secondary in the U.S.
7.2.4.1 Estimated penetration of digital pathology in pathology laboratories
7.2.4.2 Estimated penetration of digital pathology in Cancer Hospitals
7.3 Future Outlook
7.3.1 User Perspective Analysis
7.3.1.1 Consumer behaviour analysis
7.3.1.2 Market influencer analysis
7.3.1.2.1 Consumer preference
7.3.1.2.2 Technology trends
7.3.1.2.3 Cost of implementation
7.3.2 Opportunity Analysis
7.3.2.1 Potential growth for digital pathology solutions
7.3.2.2 Market Entry Strategies
7.3.2.3 Regulatory requirements for new players
7.3.2.4 Competitive Strategies
7.4 Covid-19 Impact Analysis
7.4.1 COVID-19 Outbreak
7.4.2 Current Scenario
7.4.3 Demand Analysis
Chapter 8 North America Digital Pathology Market Competitive & Vendor Landscape
8.1 Participation Categorization
8.2 Public Companies
8.2.1 Estimated Company Market Share Analysis, 2020
8.2.2 Company market position analysis
8.3 Private Companies
8.3.1 Company market position analysis
8.3.2 Regional network map
8.3.3 List of emerging companies
8.4 Recent Developments & Impact Analysis, By Key Market Participants
8.4.1 Strategic Initiatives & Outcome Analysis
8.5 Major Deals And Strategic Alliances Analysis
8.6 Case Study
8.7 Detailed List of Players
8.7.1 List Of Distributors
8.7.2 List Of Key Companies, by Region
Chapter 9 Company Profiles
9.1 Danaher
9.1.1 Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.2 Hamamatsu Photonics, Inc.
9.2.1 Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic Initiatives
9.3 Koninklijke Philips N.V.
设备上装Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic Initiatives
9.4 Olympus Corporation
9.4.1 Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic Initiatives
9.5 F. Hoffmann-La Roche Ltd
9.5.1 Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic Initiatives
9.6 Mikroscan Technologies, Inc.
9.6.1 Company overview
9.6.2 FINANCIAL PERFORMANCE
9.6.3 Product benchmarking
9.6.4 Strategic Initiatives
9.7 3DHISTECH LTD
9.7.1 Company overview
9.7.2 FINANCIAL PERFORMANCE
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.8 Inspirata, Inc。
9.8.1 Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.9 Visiopharm A/S
9.9.1 Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.10 Huron Technologies International, Inc.
9.10.1 Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
Chapter 10 Key Opinion Leader (KOL) Commentary

List of Tables

Table 1 List of Abbreviations
Table 2 Cost breakdown: digital pathology
Table 3 List of hospitals in the U.S.
Table 4 List of pathology labs in the U.S.
Table 5 Digital Pathology Guidelines in North America
Table 6 Some of the strategic collaboration related to AI in medical imaging
Table 7 List of emerging companies
Table 8 List of distributors
Table 9 List of Key Companies, by Region

List of Figures

Fig. 1 Market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Commodity workflow analysis
Fig. 10 North America Digital Pathology Market revenue, 2016 - 2027 (USD Million)
Fig. 11 North America Digital Pathology Market snapshot
Fig. 12 North America Digital pathology Country outlook
Fig. 13 U.S. Digital Pathology market, 2016 - 2028 (USD Million)
Fig. 14 Canada Digital Pathology market, 2016 - 2028 (USD Million)
Fig. 15 Competitive insights
Fig. 16 North America Digital Pathology Market Product outlook: Key takeaways
Fig. 17 North America Digital Pathology Market: Product movement analysis
Fig. 18 Software market, 2016 - 2028 (USD Million)
Fig. 19 Device market, 2016 - 2028 (USD Million)
Fig. 20 North America Digital Pathology Market Application Outlook: Key takeaways
Fig. 21 North America Digital Pathology Market: Application Movement Analysis
Fig. 22 Drug discovery & development market, 2016 - 2028 (USD Million)
Fig. 23 Academic research market, 2016 - 2028 (USD Million)
Fig. 24 Disease diagnosis market, 2016 - 2028 (USD Million)
Fig. 25 Cancer cell detection market, 2016 - 2028 (USD Million)
图26个其他应用程序市场,2016 - 2028(合D Million)
Fig. 27 North America Digital Pathology Market End-use outlook: Key takeaways
Fig. 28 North America Digital Pathology Market: End-use movement analysis
Fig. 29 Cancer hospitals market, 2016 - 2028 (USD Million)
Fig. 30 Diagnostic laboratories market, 2016 - 2028 (USD Million)
Fig. 31 Independent pathology laboratories market, 2016 - 2028 (USD Million)
Fig. 32 Large pathology laboratories market, 2016 - 2028 (USD Million)
Fig. 33 Academic and research institutes market, 2016 - 2028 (USD Million)
Fig. 34 Parent market outlook
Fig. 35 Ancillary Market Outlook
Fig. 36 Penetration & growth prospect mapping
Fig. 37 North America Digital Pathology Market dynamics
Fig. 38 North America Digital Pathology Market driver impact
Fig. 39 North America Digital Pathology Market restraint impact
Fig. 40 North America Digital Pathology Market: Porter’s five forces analysis
Fig. 41 SWOT Analysis, By Factor (Political & legal, economic and technological)
Fig. 42 U.S. Total Number of Pathology Laboratories, 2016 - 2025 ( Units )
Fig. 43 U.S. Total Number of Pathology Laboratories by Size of Laboratories, 2020 (% )
Fig. 44 U.S. Total Number of Hospitals, 2016 - 2025 (Units )
Fig. 45 U.S. Total Number of Hospitals by Specialty, 2020 (% )
Fig. 46 U.S. Total Number of Academic & Research Institutes, 2016 - 2025 ( Units )
Fig. 47 Digital Pathology Consumer Survey
Fig. 48 U.S. Digital Pathology: Primary vs secondary diagnosis, 2020 (%)
Fig. 49 U.S. Digital Pathology Penetration in pathology labs rate as of 2020 (%)
Fig. 50 U.S. Digital Pathology Penetration rate in cancer hospitals as of 2020 (%)
Fig. 51 Parameters considered by buyers for selecting digital pathology solutions
Fig. 52 Consumer behaviour analysis
Fig. 53 Market influencer analysis
Fig. 54 Recent developments & impact analysis, by key market participants in AI in medical imaging
Fig. 55 Market Participant Categorization
Fig. 56 Company Market Share Analysis, 2020
Fig. 57 Company market position analysis
Fig. 58 Company market position analysis
Fig. 59 Regional network map
Fig. 60 Key Companies and strategies
Fig. 61 Strategy mapping
Fig. 62 Digital Pathology: Case Study